CD28 and Alzheimer disease: The percentage increase of CD3+CD8+ cytotoxic/suppressor T cells bearing CD152+/CD28+ markers was found higher in AD patients than that in controls (11.9 ± 7.1 vs. 5.7 ± 3.9, p < 0.05, respectively).